相关概念视频
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.9K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.9K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
您也可能阅读
相关文章
通过共同作者、期刊和引用图与本文相关的文章。
排序
Same author
Mucus Plug Formation is Associated with Eosinophilic Activation in Chronic Obstructive Pulmonary Disease.
American journal of respiratory and critical care medicine·2026
Same author
Every Exacerbation Counts: Shifting the Dial for Future Exacerbation Risk.
American journal of respiratory and critical care medicine·2026
关于慢性阻塞性肺病的精选更新
Jordina Mah1, Andrew I Ritchie1,2, Lydia J Finney1,3
1National Heart and Lung Institute, Imperial College London, London.
Current opinion in pulmonary medicine
|December 15, 2023
概括
慢性阻塞性肺病 (COPD) 研究强调其全球影响,特别是在低收入国家. 新的发现将空气污染与COPD恶化联系在一起,并表明生物治疗可能为管理这种可预防的疾病提供新的希望.
科学领域:
- 肺部病理学 肺部病理学
- 环境健康 环境健康
- 流行病学 流行病学
背景情况:
- 慢性阻塞性肺病 (COPD) 是一个重大的全球健康挑战,是全球第三大死亡原因.
- 尽管可以预防,但COPD的患病率正在增加,特别是在低收入和中等收入国家.
- 了解COPD的流行病学和病理生理学对于开发有效干预措施至关重要.
研究的目的:
- 审查COPD研究的最新进展.
- 更新对COPD流行病学和病理生理学的理解.
- 突出新研究对疾病管理和治疗的影响.
主要方法:
- 关于COPD最近的流行病学研究的综述.
- 对空气污染对COPD发展和恶化影响的研究分析.
- 检查新兴生物标志物及其在生物制剂临床试验中的作用.
主要成果:
- 全球COPD患病率正在上升,对低收入和中等收入国家产生重大影响.
- 有证据表明,空气污染和COPD恶化之间存在联系,这需要进一步的研究和政策影响.
- 了解早期疾病起源的进展为早期干预提供了潜力.
- 诸如外周血液中埃索诺菲利亚之类的生物标志物正在指导针对性生物疗法的发展.
结论:
- 最近的研究为COPD流行病学和病理生理学提供了关键的见解.
- 空气污染成为COPD恶化的重要因素,需要考虑环境政策.
- 针对TH2炎症的生物制剂的开发代表了COPD治疗的有希望的新前沿.